These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2094063)

  • 1. Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.
    Bando S; Yamamoto H; Nishikado A; Hamai K; Fujino K; Nakaya Y; Shinohara A
    Tokushima J Exp Med; 1990 Dec; 37(3-4):69-73. PubMed ID: 2094063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
    Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
    Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of isoproterenol on quinidine induced torsade de pointes.
    Yamamoto H; Bando S; Nishikado A; Shinohara A; Hamai K; Yamamoto K; Ikefuji H; Ito S
    Tokushima J Exp Med; 1991 Jun; 38(1-2):1-4. PubMed ID: 1948996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
    Di Diego JM; Belardinelli L; Antzelevitch C
    Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iatrogenic torsade de pointes induced by thioridazine].
    Paoloni P; Ciliberti D; Blasi N; Capone P
    Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced QT dispersion: does it predict the risk of torsade de pointes?
    Shah RR
    J Electrocardiol; 2005 Jan; 38(1):10-8. PubMed ID: 15660342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval.
    Chinushi M; Izumi D; Komura S; Ahara S; Satoh A; Furushima H; Washizuka T; Aizawa Y
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):121-7. PubMed ID: 17031266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
    Vos MA; Verduyn SC; Gorgels AP; Lipcsei GC; Wellens HJ
    Circulation; 1995 Feb; 91(3):864-72. PubMed ID: 7828315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsade de pointes associated with encephalitis.
    Alehan D; Ceviz N; Celiker A
    Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.
    Hoshino K; Ogawa K; Hishitani T; Isobe T; Etoh Y
    Pediatr Int; 2006 Apr; 48(2):112-7. PubMed ID: 16635167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de pointes: prevention and therapy.
    Keren A; Tzivoni D
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):509-13. PubMed ID: 1854660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sotalol and torsades de pointes ventricular tachycardia].
    Petersen HH; Sandøe E
    Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.